GEXVal CEO to Speak at Shonan Visionaries Forum IV

GEXVal Inc.
November 20, 2026
GEXVal CEO to Speak at Shonan Visionaries Forum IV
Unlocking hidden potential with AI: a circular economy for drug discovery
GEXVal Inc. (President & CEO: Juran Kato, PhD; Fujisawa, Kanagawa, Japan; hereinafter "GEXVal") is pleased to announce that President & CEO Dr. Juran Kato will speak at Shonan Visionaries Forum IV, hosted by Kanagawa Prefecture and co-organized by Yokohama National University and the Kanagawa Institute of Industrial Science and Technology (KISTEC). The forum will be held on November 27, 2026, at Shonan Health Innovation Park (Shonan iPark) in Fujisawa, Kanagawa, where GEXVal is headquartered.
Dr. Kato will speak in the session "Where Commercialization Stands Today" as an industry-trained researcher working to bring science into real-world use, and will also join the panel discussion. Through the forum, GEXVal will share insights on what it takes to bring research to patients and further strengthen its collaboration with the innovation ecosystem of the Shonan region, its home base.
[Presentation Overview]
In her talk, Dr. Kato will introduce the concept of a "circular economy for drug discovery": using RePhaIND®, GEXVal's proprietary AI drug discovery platform, to uncover overlooked opportunities across the pharmaceutical industry, from compounds whose development was discontinued to novel compounds whose value has yet to be recognized, and bringing them back into circulation as new treatment options. Drawing on her own path from drug discovery researcher to founder, she will also share practical insights gained from advancing clinical development overseas and building partnerships with patient advocacy groups, as well as GEXVal's next steps toward global development.
The panel discussion will explore "The Role of the Ecosystem in Connecting Research Concepts to Real-World Implementation."
**Presentation Details**
|
Event |
Shonan Visionaries Forum IV |
|
Organizers |
Hosted by Kanagawa Prefecture; co-organized by Yokohama National University and KISTEC |
|
Date |
Friday, November 27, 2026, 15:00–18:00 JST (networking reception 18:00–19:30) |
|
Venue |
Shonan iPark, 2-26-1 Muraoka-Higashi, Fujisawa, Kanagawa, Japan |
|
Sessions |
・Session 2: Where Commercialization Stands Today |
|
Registration |
Free; advance registration required by 12:00 JST, Wednesday, November 25 |
[About GEXVal]
GEXVal strives to create and develop innovative pharmaceuticals for unmet medical needs, in pursuit of our mission, Treatment Reaching the Unreached with focus on rare diseases and underserved medical conditions. By leveraging our proprietary AI-powered pharmacoinformatics technology, we illuminate paths to breakthrough therapies, identifying hidden potential in drug candidates to deliver life-changing medicines that bring new hope to patients and their families.
For further information:
Head of Corporate Office
Atsushi Sugizaki
info@gexval.com

